CMCasper Louk de Mol

Casper Louk de Mol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Casper Louk de Mol has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis

    by Cato E. A. Corsten, Ana M. Marques, Elisabeth J. Vinke, C. Louk de Mol, Rinze F. Neuteboom, M. Kamran Ikram, Mohsen Ghanbari, Frank J. Wolters, Beatrijs Wokke, Meike W. Vernooij, et al.

    The risk allele rs10191329*A is associated with disease severity and brain atrophy in people with multiple sclerosis (MS). We investigated the association of rs10191329 with age‐related brain atrophy in a population‐based cohort using 10,308 magnetic resonance imaging (MRI) scans of 4,815 participants aged ≥ 45 years without MS in cross‐sectional and longitudinal analyses. We observed associations between the rs10191329*A allele and lower total brain volume and gray matter volume in middle‐aged (< 55 years of age), but not in older participants. These data suggest that rs10191329*A contributes to earlier onset of atrophy in the general population, and that mediating mechanisms of accelerated neurodegeneration extend beyond MS. ANN NEUROL 2026;99:1083–1089


  • Open Access

    Environmental multiple sclerosis (MS) risk factors, genetic MS risk, and brain development in a general paediatric population

    by Casper Louk de Mol, Sander Lamballais, Ryan Muetzel, Liesbeth Duijts, Joost Smolders, Tonya White, Rinze Frederik Neuteboom

    Background: Neuroaxonal loss occurs in the early stages of multiple sclerosis (MS), but whether it results from early inflammatory brain damage or an ongoing neurodegenerative process remains unclear. We hypothesise that genetic and childhood environmental risk factors for MS may already have an impact on neurodevelopment before the typical age of onset for MS in the general population.Methods: We examined associations and interactions of genetic and environmental risk factors for MS with brain MRI outcomes, including volumetric (n=5350) and diffusion data (n=5649), at ages 9 and 13 years in a large, population-based childhood cohort without MS diagnoses. Polygenic risk scores (PRSs) were used to assess genetic burden, with rs10191329 as a marker of MS severity. Environmental factors at age 5 included Epstein-Barr virus (EBV) serology, vitamin D status, body mass index, duration of outdoor activities, and household parental smoking.Results: Genetic data were available for 2817 and 2970 participants with volumetric and diffusion data, respectively. The MS-PRS was positively associated with EBV viral capsid antigen titres among EBV-positive children (β=0.15, p=2.98×10−6). A negative association was observed between the MS-PRS and subcortical grey matter volume (β=−0.03, p=0.014). Interaction between the MS-PRS and household parental smoking was negatively linked to total brain (β=−0.21, p=0.025) and thalamic volumes (β=−0.22, p=0.003), where a higher MS-PRS and household smoking were associated with lower volumes. No associations were observed for rs10191329 with brain outcomes.Conclusions: Genetic and environmental risk factors for MS interact to influence brain volumes in childhood, suggesting a potential window for preventing MS in genetically susceptible individuals by reducing exposure to household smoking.


  • Open Access

    Multiple sclerosis risk variants influence the peripheral B‐cell compartment early in life in the general population

    by Casper L. de Mol, Marvin M. van Luijn, Karim L. Kreft, Kirsten I. M. Looman, Menno C. van Zelm, Tonya White, Henriette A. Moll, Joost Smolders, Rinze F. Neuteboom

    Background and purpose: Multiple sclerosis (MS) is associated with abnormal B‐cell function, and MS genetic risk alleles affect multiple genes that are expressed in B cells. However, how these genetic variants impact the B‐cell compartment in early childhood is unclear. In the current study, we aim to assess whether polygenic risk scores (PRSs) for MS are associated with changes in the blood B‐cell compartment in children from the general population.Methods: Six‐year‐old children from the population‐based Generation R Study were included. Genotype data were used to calculate MS‐PRSs and B‐cell subset‐enriched MS‐PRSs, established by designating risk loci based on expression and function. Analyses of variance were performed to examine the effect of MS‐PRSs on total B‐cell numbers (n = 1261) as well as naive and memory subsets (n = 675).Results: After correction for multiple testing, no significant associations were observed between MS‐PRSs and total B‐cell numbers and frequencies of subsets therein. A naive B‐cell‐MS‐PRS (n = 26 variants) was significantly associated with lower relative, but not absolute, naive B‐cell numbers (p = 1.03 × 10−4 and p = 0.82, respectively), and higher frequencies and absolute numbers of CD27+ memory B cells (p = 8.83 × 10−4 and p = 4.89 × 10−3, respectively). These associations remained significant after adjustment for Epstein–Barr virus seropositivity and the HLA‐DRB1*15:01 genotype.Conclusions: The composition of the blood B‐cell compartment is associated with specific naive B‐cell‐associated MS risk variants during childhood, possibly contributing to MS pathophysiology later in life. Cell subset‐specific PRSs may offer a more sensitive tool to define the impact of genetic risk on the immune system in diseases such as MS.


  • Open Access

    White matter microstructural differences in children and genetic risk for multiple sclerosis: A population-based study

    by C Louk de Mol, Rinze F Neuteboom, Philip R Jansen, Tonya White

    MS patients show abnormalities in white matter (WM) on brain imaging, with heterogeneity in the location of WM lesions. The “pothole” method can be applied to diffusion-weighted images to identify spatially distinct clusters of divergent brain WM microstructure. To investigate the association between genetic risk for MS and spatially independent clusters of decreased or increased fractional anisotropy (FA) in the brain. In addition, we studied sex- and age-related differences. 3 Tesla diffusion tensor imaging (DTI) data were collected in 8- to 12-year-old children from a population-based study. Global and tract-based potholes (lower FA clusters) and molehills (higher FA clusters) were quantified in 3047 participants with usable DTI data. A polygenic risk score (PRS) for MS was calculated in genotyped individuals (n = 1087) and linear regression analyses assessed the relationship between the PRS and the number of potholes and molehills, correcting for multiple testing using the False Discovery Rate. The number of molehills increased with age, potholes decreased with age, and fewer potholes were observed in girls during typical development. The MS-PRS was positively associated with the number of molehills (β = 0.9, SE = 0.29, p = 0.002). Molehills were found more often in the corpus callosum (β = 0.3, SE = 0.09, p = 0.0003). Genetic risk for MS is associated with spatially distinct clusters of increased FA during childhood brain development.


  • Open Access

    T cell composition and polygenic multiple sclerosis risk: A population‐based study in children

    by Casper L. de Mol, Kirsten I. M. Looman, Marvin M. van Luijn, Karim L. Kreft, Philip R. Jansen, Menno C. van Zelm, Joost J. F. M. Smolders, Tonya J. H. White, Henriette A. Moll, Rinze F. Neuteboom

    Background and purpose: Patients with multiple sclerosis (MS) have altered T cell function and composition. Common genetic risk variants for MS affect proteins that function in the immune system. It is currently unclear to what extent T cell composition is affected by genetic risk factors for MS, and how this may precede a possible disease onset. Here, we aim to assess whether an MS polygenic risk score (PRS) is associated with an altered T cell composition in a large cohort of children from the general population.Methods: We included genotyped participants from the population‐based Generation R study in whom immunophenotyping of blood T cells was performed at the age of 6 years. Analyses of variance were used to determine the impact of MS‐PRSs on total T cell numbers (n = 1261), CD4+and CD8+lineages, and subsets therein (n= 675). In addition, T‐cell‐specific PRSs were constructed based on functional pathway data.Results: The MS‐PRS negatively correlated with CD8+T cell frequencies (p = 2.92 × 10−3), which resulted in a positive association with CD4+/CD8+T cell ratios (p = 8.27 × 10−9). These associations were mainly driven by two of 195 genome‐wide significant MS risk variants: the main genetic risk variant for MS,HLA‐DRB1*15:01and anHLA‐Brisk variant. We observed no significant associations for the T‐cell‐specific PRSs.Conclusions: Our results suggest that MS‐associated genetic variants affect T cell composition during childhood in the general population.


  • Open Access

    Prevalence of radiologically isolated syndrome in a pediatric population-based cohort: A longitudinal description of a rare diagnosis

    by Cl de Mol, AL Bruijstens, Pr Jansen, Mhg Dremmen, Yym Wong, A van der Lugt, Tjh White, Rf Neuteboom

    Background: Radiologically isolated syndrome (RIS) is typified by multiple sclerosis (MS)-like lesions on imaging, without clinical MS symptoms. The prevalence of pediatric RIS is largely unknown. Objective: The objective of the study is to provide an estimated RIS prevalence in a population-based cohort of children. Methods: We used data from the Generation R study to identify the childhood RIS prevalence. Results: In 5238 participants, only one RIS case was identified (prevalence: 0.02%; 95% confidence interval (CI): 0.00–0.11). During a 62-month follow-up, imaging examinations showed accrual of new focal demyelinating lesions; however, no clinical MS symptoms occurred. Conclusions: This study shows that the occurrence of RIS in children from the general population is rare.


  • Open Access

    Polygenic Multiple Sclerosis Risk and Population‐Based Childhood Brain Imaging

    by C. Louk de Mol, Philip R. Jansen, Ryan L. Muetzel, Maria J. Knol, Hieab H. Adams, Vincent W. Jaddoe, Meike W. Vernooij, Rogier Q. Hintzen, Tonya J. White, Rinze F. Neuteboom

    Objective: Multiple sclerosis (MS) is a neurological disease with a substantial genetic component and immune‐mediated neurodegeneration. Patients with MS show structural brain differences relative to individuals without MS, including smaller regional volumes and alterations in white matter (WM) microstructure. Whether genetic risk for MS is associated with brain structure during early neurodevelopment remains unclear. In this study, we explore the association between MS polygenic risk scores (PRS) and brain imaging outcomes from a large, population‐based pediatric sample to gain insight into the underlying neurobiology of MS.Methods: We included 8‐ to 12‐year‐old genotyped participants from the Generation R Study in whom T1‐weighted volumetric (n = 1,136) and/or diffusion tensor imaging (n = 1,088) had been collected. PRS for MS were calculated based on a large genome‐wide association study of MS (n = 41,505) and were regressed on regional volumes, global and tract‐specific fractional anisotropy (FA), and global mean diffusivity using linear regression.Results: No associations were observed for the regional volumes. We observed a positive association between the MS PRS and global FA (β = 0.098, standard error [SE] = 0.030, p = 1.08 × 10−3). Tract‐specific analyses showed higher FA and lower radial diffusivity in several tracts. We replicated our findings in an independent sample of children (n = 186) who were scanned in an earlier phase (global FA; β = 0.189, SE = 0.072, p = 9.40 × 10−3).Interpretation: This is the first study to show that greater genetic predisposition for MS is associated with higher global brain WM FA at an early age in the general population. Our results suggest a preadolescent time window within neurodevelopment in which MS risk variants act upon the brain. ANN NEUROL 2020;87:774–787


  • Top Cited Papers
    Open Access

    The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults

    by Cl de Mol, Yym Wong, Ed van Pelt, Bha Wokke, Tam Siepman, Rf Neuteboom, D Hamann, Rq Hintzen

    Objectives: The aim of this study was to assess the Dutch nationwide incidence of myelin oligodendrocyte glycoprotein (MOG)-IgG-associated acquired demyelinating syndromes (ADS) and to describe the clinical and serological characteristics of these patients. Methods: All serum samples for routine diagnostics from February 2014 to December 2017 were sent to the single central reference laboratory for the full-length MOG-IgG cell-based assay (CBA) in the Netherlands. Clinical data from patients known in our National ADS centre were available. Results: A total of 1414 samples of 1277 patients were received; of these, 92 patients (7%) were MOG-IgG-seropositive. The mean incidence was 0.16/100,000 people, with higher seropositivity in children (0.31/100,000) than in adults (0.13/100,000). In MOG-IgG-positive patients at the National ADS centre (61/92, 66%), the most common presenting phenotype is acute disseminated encephalomyelitis (ADEM, 56%) in children and optic neuritis (ON, 44%) in adults. Relapsing disease occurred in 9/34 (26%) children and 11/27 (41%) adults during median follow-up of 27.5 months. Patients were tested MOG-IgG-positive >200 months after the initial attack, suggesting an extended time to first relapse (TTFR). Longitudinal analysis of MOG-IgG (25/61, 41%) showed that 67% of the monophasic patients remain seropositive and 60% in relapsing patients. Majority of seronegative patients had no relapses (89%). Conclusion: This nationwide study shows that the overall incidence of MOG-IgG-seropositive disorders is 0.16 per 100,000 people. The distribution over the clinical phenotypes differs between adults and children. Seropositivity can be maintained over years even without clinical activity, while seronegative patients generally had no relapses.